GlassScriptPhysician profile
Stephen A Boykins
NPI 1689014318
$3,385.00
in general payments reported to CMS, 2019-2025
23 companies · $236 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,471 · 2020: $204 · 2021: $323 · 2022: $385 · 2023: $267 · 2024: $499 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,344.89 | 2019 | |
| Cardiovascular Systems INC. | $429.78 | 2020-2022 | |
| Organogenesis INC. | $262.16 | 2020-2024 | Puraply Franchise |
| Horizon Therapeutics Plc | $243.44 | 2022-2023 | Krystexxa |
| Smith+Nephew, INC. | $216.27 | 2022-2025 | Stravix, Grafix Pl, Oasis |
| Tactile Systems Technology INC | $185.78 | 2020-2023 | Entre Plus, Flexitouch Plus |
| Paratek Pharmaceuticals, INC. | $142.72 | 2023-2025 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $125.77 | 2019 | |
| Kerecis Limited | $60.33 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Nevro Corp. | $48.18 | 2023 | Senza |
| Angiodynamics, INC. | $43.90 | 2022 | |
| Stryker Corporation | $42.82 | 2024 | Prostep Mica |
| Bioventus LLC | $39.99 | 2020-2024 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $31.85 | 2025 | Krystexxa |
| Medtronic, INC. | $31.55 | 2024 | Intellis Adaptivestim |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $28.89 | 2021-2022 | |
| Averitas Pharma INC. | $23.91 | 2024 | Qutenza |
| Orthofix Medical, INC. | $16.56 | 2025 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $16.05 | 2021 | |
| Mimedx Group, INC. | $15.58 | 2025 | |
| Solventum Corporation | $14.91 | 2025 | Activ.A.C. |
| Melinta Therapeutics, LLC | $14.42 | 2020 | |
| Next Science LLC | $5.25 | 2023 | Blastx, Xperience, Surgx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Boykins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.